Data from Preclinical and Dose-Finding Phase I Trial Results of Combined Treatment with a TORC1/2 Inhibitor (TAK-228) and Aurora A Kinase Inhibitor (Alisertib) in Solid Tumors
Open Access
- 31 March 2023
- other
- Published by American Association for Cancer Research (AACR)